Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Gynecologic 3 Thoracic 1 Sarcoma 1 Dermatologic 1 Breast 1

Conditions

Gastrointestinal Stromal Tumors 1

Interventions

Specimen Handling 38 Magnetic Resonance Spectroscopy 32 Cyclophosphamide 30 Doxorubicin 24 Biopsy 23 pembrolizumab 22 Temozolomide 22 Radiotherapy 19 X-Rays 18 Radiation 18 Nivolumab 15 Vincristine 13 Irinotecan 13 fludarabine 12 Phantoms, Imaging 12 Ifosfamide 12 Gemcitabine 12 atezolizumab 11 cabozantinib 10 Ipilimumab 9 Bevacizumab 9 liposomal doxorubicin 8 Surgical Procedures, Operative 8 Paclitaxel 8 Immunoglobulin G 8 Etoposide 8 Dactinomycin 7 Carboplatin 7 palbociclib 6 olaparib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Laparoscopy × Sarcoma × 90 days × Clear all

NCT07550582 2026-04-30

SAVE-GEJ

Peking University People's Hospital

Phase 2 Enrolling by invitation

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡